Application 063024
- Type
- ANDA
- Sponsor
- TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEPHALEXIN | CEPHALEXIN | TABLET;ORAL | EQ 500MG BASE | No | Yes |
| 002 | CEPHALEXIN | CEPHALEXIN | TABLET;ORAL | EQ 250MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-2240 | Cephalexin | Cephalexin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-2240 | Cephalexin | Cephalexin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-2240 | Cephalexin | Cephalexin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-2240 | Cephalexin | Cephalexin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-2240 | Cephalexin | Cephalexin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-2240 | Cephalexin | Cephalexin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-2240 | Cephalexin | Cephalexin | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 39403 | SUPPL | 2012-07-30 |